The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

A new study published in Current Molecular Pharmacology explores the transformative role of large language models (LLMs) in drug development. The research highlights how LLMs enhance efficiency and ...

A newly discovered receptor switch that boosts bone growth could transform how we treat osteoporosis, by stimulating the body ...

The pharmaceutical industry is undergoing a transformative shift fueled by data analytics. As drug development becomes increasingly complex, analytics is emerging as a key enabler of innovation and ...

Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular dysfunction today announced that the first patient has ...

Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include ...

Drug repurposing - identifying new uses for existing medications- has emerged as a transformative approach in oncology, offering a cost-effective and ...

In the realm of veterinary medicine, viral diseases present a persistent challenge, significantly impacting livestock health and productivity. Traditional ...

Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to ...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.16 EPS, expectations were $0 ...

Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to the same ...